SU-E-T-448: Switch Patients between Collimation Systems for CyberKnife Treatment Feasibility Study.

J Fan1,2, Q Xu1,2, L Wang1,2

  • 1Fox Chase Cancer Center, Philadelphia, PA.

Medical Physics
|May 19, 2017
PubMed
Summary

Switching CyberKnife collimation systems is feasible without replanning. Adjusting Iris collimator sizes ensures similar dose distributions, allowing safe transitions between Iris and fixed cone collimators for cancer treatment.

Related Concept Videos